Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
Research output: Contribution to journal › Article › peer-review
10Citations
(Scopus)
169Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer'. Together they form a unique fingerprint.